Loading cancer entity…
Loading cancer entity…
Variants & evidence
2 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|
| DICER1 D1810Y1 | |||||||
| (oncogenic) | Oncogenic | D | Supports Oncogenicity | 2 | submitted | EID6093Sanger sequencing of several pleuropulmonary blastoma tumor lines showed possible somatic missense mutation, D1810Y, in DicerI. All mutations thought to be somatic were found in the RNase IIIb domain.… (full text at CIViC) PMID 24675358 · Seki et al., 2014 · Open in CIViC | civic |
| DICER1 E1813D + DICER1 R392fs1 | |||||||
| (oncogenic) | Oncogenic | C | Supports Oncogenicity | 1 | submitted | EID7059These two mutations were identified in the tumor tissue in an NGS based panel and were not seen in the adjacent normal lung tissue. This confirms it as a rare case of somatically acquired Biallelic mu… (full text at CIViC) PMID 24909177 · Pugh et al., 2014 · Open in CIViC | civic |
Data updated 8 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.